Doximity (DOCS)
Connects U.S. clinicians with marketing, hiring, and workflow tools.
Something off on this page? Send us feedback.
Runs a verified U.S. clinician network and sells Marketing, Hiring, and Workflow Solutions to pharmaceutical companies and health systems. Telehealth, news and research, career, scheduling, communications, and clinical-AI tools extend the platform.
Runs a virtual community for U.S. clinicians. Its tools support collaboration, patient-care coordination, virtual visits, current medical information, and career management, while bringing together telehealth, news and research, digital fax and e-signature, and Amion scheduling for clinician members.
Subscription-based Marketing, Hiring, and Workflow Solutions are sold principally to pharmaceutical companies and health systems. The Clinical AI Suite includes Ask, Scribe, and Dialer, while the Pathway acquisition added medical-AI clinical-reference capabilities.
Reliable handling of clinician and healthcare-related information, privacy and healthcare regulation, third-party systems, and continued clinician and enterprise-customer adoption shape the business.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 8, 2026 | Stifel Nicolaus | Target | Target: — | Target: $27 |
| Sep 8, 2026 | Freedom Capital Markets | Downgrade | ||
| Aug 13, 2026 | Wolfe Research | Upgrade | Rating: — | |
| Aug 13, 2026 | Truist Financial | Target | Target: $19 | Target: $24 |
| Aug 10, 2026 | Wells Fargo | Downgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $687.8M · Total debt $9.7M · Total assets $1.08B · Shareholders' equity $916.1M
- Revenue
- $156.6M
- Operating income
- $33.6M
- Net income
- $24.3M
No dividends on record.
| Institutions | ≈ 72.89% | 129.92M shares | |
|---|---|---|---|
| 379 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 32.23% | 57.44M shares | |
| 10 holders · as of Sep 16, 2026 | |||
| Strategic holders | 10.98% | 19.58M shares | |
| 2 holders · as of Jan 25, 2024 | |||
| Adds to | 116.10% | ||
178.25M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 116.10%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Jeffrey Tangney1,2,3Insiderdirector, 10 percent owner, officer: Chief Executive Officer | 31.28% | 55.46M COMPANY | filed Aug 17, 2026 |
BlackRock, Inc.Institution | 8.03% | 14.31M A | as of Jun 30, 2026 |
BlackRock, Inc.Strategic | 5.91% | 10.54M | filed Jan 25, 2024 |
Interwest Partners X LP4,5Strategic10 percent owner | 5.07% | 9.04M A | filed Feb 14, 2022 |
T. Rowe Price Associates, Inc.Institution | 4.33% | 7.72M | filed Aug 10, 2022 |
- Jeffrey Tangney's transaction reports restate only vehicles that traded; the 2026 ownership statement (55.46M) plus the 299.1K net shares acquired since is used instead.
- Jeffrey Tangney reports a block also reported by Geode Capital Management, LLC; it is counted once, under Geode Capital Management, LLC.
- Jeffrey Tangney reports a block also reported by another filer; it is counted once, under that filer.
- Interwest Partners X LP's transaction reports restate only vehicles that traded; the 2022 ownership statement (9.04M) is used instead.
- Interwest Partners X LP reports a block also reported by another filer; it is counted once, under that filer.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 15, 2026 | Siddharth Sitaram | officer: Chief Accounting Officer | −2,077 | $26.02 |
| Sep 1, 2026 | Kira Scherer Wampler | director | −2,000 | $26.33 |
| Aug 25, 2026 | Kira Scherer Wampler | director | −2,000 | $24.95 |
| Aug 13, 2026 | Siddharth Sitaram | officer: Chief Accounting Officer | −1,770 | $24.94 |
| Aug 7, 2026 | Timothy S. Cabral | director | −7,500 | $39.11 |
- Veeva Systems
Life-sciences commercial cloud for pharma HCP engagement
- IQVIA
Pharma commercialization and HCP-engagement services
- Definitive Healthcare
Healthcare commercial intelligence and provider data
- AMN
Clinician recruitment and workforce services for health systems
- Teladoc Health
Enterprise virtual-care platform and clinician services
- Amwell
Virtual-care platform and clinical programs for health systems
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Doximity | $26.68 | −0.60% | $5.02B | 31.6 | 19.1 | 7.7 | +7.3% |
| Veeva Systems | $263.17 | +0.71% | $42.45B | 43.0 | 27.3 | 12.3 | +17.6% |
| IQVIA | $270.80 | +0.34% | $44.42B | 33.5 | 19.9 | 2.6 | +8.7% |
| Definitive Healthcare | $0.9195 | +2.17% | $95.0M | — | 5.3 | 0.4 | −9.1% |
| AMN | $34.19 | −0.15% | $1.33B | 12.8 | 40.7 | 0.4 | +2.3% |
| Teladoc Health | $6.27 | 0.00% | $1.14B | — | — | 0.5 | −4.0% |
| Amwell | $13.35 | −0.52% | $228.3M | — | — | 1.0 | −26.6% |
| Median | 33.5 | 23.6 | 0.8 | −0.8% |